JWH-210(sales3@kaseeypharm.com)

Email: sales3 at kaseeypharm.com Skype :Lee.Caseey JWH-210 is an analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid agonist at both the CB1 and CB2 receptors, with Ki values of 0.46nM at CB1 and 0.69nM at CB2. It is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher binding affinity (i.e. lower Ki) at CB1 than both its 4-methyl and 4-n-propyl homologues JWH-122 (CB1 Ki 0.69nM) and JWH-182 (CB1 Ki 0.65nM) respectively, and than the 4-methoxy compound JWH-081 (CB1 Ki 1.2nM).[2] It was discovered by and named after Dr. John W. Huffman. JWH-210 and JWH-122 were banned in Sweden on 1st October 2010 as hazardous goods harmful to health, after being identified as ingredients in "herbal" synthetic cannabis products.[3][4] The substance JWH-210, JWH-122 and JWH-203 were classified as illegal drugs by the Swedish government as of 1 September, 2011.[5]  Detailed info: CAS# 824959-81-1 Systematic name: 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone Purity 99%+ Lab. location: Asia (CN)